KATIE SANFORD: Open Payments
NPI 1336700434 · FERN PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 21 payments from 12 companies in 2025. Trend: 2023 $156 · 2024 $14 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $148 |
| Novo Nordisk Inc | 4 | $145 |
| Exact Sciences Corporation | 2 | $53 |
| Lilly USA, LLC | 2 | $52 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| ABBVIE INC. | 2 | $30 |
| Corcept Therapeutics | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: AIRSUPRA, Wegovy, MOUNJARO, TRELEGY ELLIPTA, VRAYLAR, Cologuard Collection Kit, The Cologuard Plus Collection Kit, Korlym.
Industry payments across FL — which companies pay providers there.
